Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Olema Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 97 | 113 | +16 |
| Shares | 47.3M | 51.6M | +4.30M (+9.1%) |
| Value | $584.4M | $717.1M | +$132.6M (+22.7%) |
New holders (33)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (17)
Institutions that held Olema Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Kynam Capital Management, LP | 235,176 | $2.90M |
| Vontobel Holding Ltd. | 164,282 | $2.03M |
| Acuta Capital Partners, LLC | 153,007 | $1.89M |
| Aquilo Capital Management, LLC | 88,875 | $1.10M |
| Driehaus Capital Management LLC | 86,625 | $1.07M |
| Bridgeway Capital Management, LLC | 86,487 | $1.07M |
| Schonfeld Strategic Advisors LLC | 72,369 | $893.8K |
| Endurant Capital Management LP | 58,573 | $723.4K |
| Algert Global LLC | 47,630 | $588.2K |
| Raymond James & Associates | 30,000 | $370.5K |
| Caxton Associates LP | 13,474 | $166.4K |
| Raymond James Financial Services Advisors, Inc. | 13,287 | $164.1K |
| Trexquant Investment LP | 11,151 | $137.7K |
| Dorsey Wright & Associates | 2,858 | $35.3K |
| Public Employees Retirement System of Ohio | 2,850 | $35.0K |
| Federated Hermes, Inc. | 1,035 | $12.8K |
| Advisor Group Holdings, Inc. | 1 | $12 |